View Clinical Trial (Medical Research Study)

Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol

Browse Studies

City:   Philadelphia
State:   Pennsylvania
Zip Code:   19107
Conditions:   Sturge Weber Syndrome - Port Wine Mark
Purpose:   Primary Objective: • To assess the possible utility of topical timolol in the management of port-wine mark (PWM) in Sturge-Weber syndrome in children.
Study Summary:   Port-wine mark (PWM) represents a congenital capillary malformation,characterized by dilation and malformation of dermal capillaries that lack endothelial proliferation. It is frequently seen in the facial distribution of the trigeminal nerve. PWM persists throughout life and involves ~0.3% of the population. Although PWMs are found in other circumstances, ~ 3% of patients with facial PWM are also afflicted with Sturge-Weber syndrome. PWMs are cosmetic entities that often have serious social consequences, producing psychological trauma to both children and their parents. PWM does not involute with time, and, if left untreated, can develop deep purple coloration, tissue hypertrophy, and nodularity. Laser therapy, which selectively destroys specific targets within the skin, is currently the most commonly used approach for treating PWM, although complete blanching of the PWM after laser is rarely achieved for most patients, and only 10-45% of patients with Sturge-Weber have shown satisfactory outcomes. Complications of pulsed dye laser treatment for PWM include pyogenic granuloma, scabbing, cutaneous scarring, and permanent hypo/hyperpigmentation. Laser treatment is relatively contraindicated in children with darker skin coloration due to the resulting hypopigmentation which may be equally unsightly. Laser treatment causes substantial discomfort and pain to patients, and often requires general anesthesia in children. This is particularly true since earlier treatment in infancy is desirable and yields increased successful resolution of the PWM. The hypertrophic PWM in later years is resistant to any treatment. Recently, propranolol was reported to successfully treat capillary hemangioma in infants.13 While the mechanism by which beta blockade improves hemangioma is unclear, ß2-mediated vasoconstrictive effects and the ensuing apoptosis of capillary endothelial cells may contribute to the positive therapeutic results. Oral application of propranolol can cause severe systemic complications, including bronchospasm, vasospasm, hypoglycemia, hypotension, severe bradycardia, heart block, and congestive heart failure. Topical timolol solution, a β-blocker, has shown a similar ability to reduce capillary hemangioma of eyelids with little or no systemic effects in a small pilot study. Similar to capillary hemangioma, which is a proliferative lesion characterized by increased endothelial cell turnover, PWM is a capillary malformation with abnormal endothelial cells and large surface area of dilated capillaries. Thus, both capillary hemangioma and PWM share the similar characteristic of abnormal capillary endothelial cells. This pilot study is designed to explore the potential role of topical timolol in the management of PWM. As PWM is so frequently associated with Sturge-Weber syndrome, a disorder in which approximately 50% of patients will develop glaucoma, this study will be conducted in an ophthalmology setting. This study will consist of two arms. One group will receive timolol and the second group a placebo preservative free artificial tear gel. The groups will be divided with a ratio of 1:1 and the Timolol group will be matched with the placebo group by PWM location, age and race. Both medications are to be applied and rubbed in by fingertip to the treatment site twice a day for 6 months by subject's parents/guardian. (Treatment site: 1x1 cm at inferior edge of facial PWM) Follow-up schedule: 1 week after treatment initiation and then every 2 months for a period of six months.
Criteria:   Inclusion criteria: - Age from 2 years to 10 years - Port-Wine Mark - English fluent and literate substitute decision maker - Substitute decision maker vision sufficient to read informed consent document Exclusion criteria: - Active ocular infection (conjunctivitis, keratitis,) - History of systemic conditions including hypo/hypertension, hypoglycemia, bradycardia, asthma or any contraindication to beta blocker use - Unable to comply with required follow-up - Substitute decision maker not English fluent or not literate - Substitute decision maker unable to read consent document - Patient already using systemic beta-blocker or beta-agonist (Patients already using topical beta-blocker for glaucoma will not be excluded from study).
NCT ID:   NCT01533376
Primary Contact:   Principal Investigator
Alex V Levin, MD, MHSc
Wills Eye Institute

Jose A Cordovez, MD
Phone: 2159283418
Backup Contact:   Email:
Alex V Levin, MD, MHSc
Phone: 2159283918
Location Contact:   Philadelphia, Pennsylvania 19107
United States

Jose A Cordovez, MD
Phone: 215-928-3418

Site Status: Recruiting

Data Source:
Date Processed:   August 22, 2014
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing

If you would like to be contacted by the clinical trial representative please enter your contact information, then click I Am Interested In This Study

Full Name:
Email Address:
Confirm Email:
Daytime Phone (eg. 555-555-5555):
Zip Code:
Best Time to Call:

    (updated 42 minutes ago)
Within 25 Miles

Chronic Itch - Berlin NJ

Endometriosis - Stratford NJ

Endometriosis - Levittown PA

Endometriosis - Philadelphia PA

Obsessive Compulsive Disorder (OCD) - Norristown PA

Obsessive Compulsive Disorder (OCD) - Norristown PA

Brain Tumor (Glioblastoma) - Philadelphia PA

Memory Loss - Norristown PA

Adolescent Major Depression (Ages 12-17) - Cherry Hill NJ

Diabetic Foot Sores - Philadelphia PA

Adolescent Depression - Cherry Hill NJ

Bipolar Disorder - Cherry Hill NJ

Post-Traumatic Stress Disorder (PTSD) - Norristown PA

Multiple Sclerosis - Philadelphia PA

Attention Deficit Hyperactivity Disorder (ADHD) - Cherry Hill NJ

Yeast Infections - Philadelphia PA

Type 1 Diabetes - Jenkintown PA

Depression - Cherry Hill NJ

High Cholesterol - Bensalem PA

High Cholesterol - Levittown PA

High Cholesterol - Philadelphia PA

High Cholesterol - Harleysville PA

High Cholesterol - Lansdale PA

Asthma - Philadelphia PA

Asthma - Philadelphia PA

COPD (Emphysema and Chronic Bronchitis) - Marlton NJ

Within 50 Miles

Endometriosis - Newark DE

Type 2 Diabetes - Toms River NJ

Osteoarthritis of the Knee - Trenton NJ

Atrophic Vaginitis - Plainsboro NJ

Type 1 Diabetes - Trenton NJ

Diabetic Gastroparesis - Vineland NJ

High Cholesterol - Trenton NJ

Bacterial Vaginosis - Plainsboro NJ

Anemia - Plainsboro NJ

Type II Diabetes - Trenton NJ

Within 100 Miles

Chronic Itch - Verona NJ

Lupus - Reading PA

Type 2 Diabetes - Baltimore MD

Endometriosis - New York NY

Endometriosis - New York NY

Endometriosis - Hershey PA

Gout - New York NY

Pediatric Type 2 Diabetes (Ages 10-17) - New Hyde Park NY

Multiple Sclerosis (Relapsing) - Dover DE

Brain Tumor (Glioblastoma) - Hackensack NJ

Depression - New York NY

Adolescent Major Depression (Ages 12-17) - Baltimore MD

Diabetes - New York NY

Obsessive Compulsive Disorder (OCD) - New York NY

Diabetic Foot Sores – Hoboken NJ

Diabetic Foot Sores - Rosedale NY

Diabetic Foot Sores - York PA

Heart Failure After Heart Attack - New York NY

Heart Failure After Heart Attack - New York NY

Heart Failure After Heart Attack - Lemoyne PA

Alzheimer's Disease - Baltimore MD

Asthma - Nottingham MD

Temporomandibular Disorder (TMJD) - Baltimore MD

Postherpetic Neuralgia - New York NY

Heart Failure After Heart Attack - Morristown NJ

Social Anxiety Disorder - New York NY

Depression - New York NY

Adult ADHD - New York NY

Depression - New York NY

Healthy Volunteers (Age 18-50) - Baltimore MD

Chronic Obstructive Pulmonary Disease (COPD) - New York NY

Diabetic Nephropathy (Kidney Disease) - New York NY

Healthy Volunteers (Age 18-50) - Baltimore MD

Major Depression Disorder - New York NY

PBA - Pseudobulbar Affect - New York NY

Obsessive Compulsive Disorder (OCD) - New York NY

Healthy Volunteers (Age 18-55) - Baltimore MD

Healthy Volunteers (Age 18-45) - Baltimore MD

Allergies - Baltimore MD

Healthy Volunteers (Age 18-65) - Baltimore MD

Parkinson's Disease - New York NY

Healthy Volunteers (Age 18-60) - Baltimore MD

Healthy Volunteers (Age 18-49) - Baltimore MD

Healthy Volunteers (Age 25-40) - Baltimore MD

Healthy Male Volunteers (Age 18-65) - Baltimore MD

Type 2 Diabetes - Rosedale NY

Type 2 Diabetes - Towson MD

Type 2 Diabetes - Lodi NJ

Type 2 Diabetes - Brooklyn NY

Type 2 Diabetes - Staten Island NY

Fibromyalgia Pain - New York NY

Attention Deficit Hyperactivity Disorder (ADHD) - New York NY

High Cholesterol - Rosedale NY

High Cholesterol - Mineola NY

High Cholesterol - Linden NJ

High Cholesterol - Lodi NJ

Asthma - Asbury Park NJ

Ankle Sprain - Towson MD

Healthy Volunteers (Age 18-60) - Baltimore MD

Polycystic Kidney Disease (PKD) - Autosomal Dominant (ADPKD) - New York NY

Healthy Female Volunteers (Age 50-65) - Baltimore MD

Healthy Volunteers (Age 18-65) - Baltimore MD

Healthy Male Volunteers (Age 18-56) - Baltimore MD

Healthy Female Volunteers (Age 18-56) - Baltimore MD

Migraines - Pikesville MD

Eczema - Baltimore MD

Healthy Volunteers (Age 50-80) - Baltimore MD

High Cholesterol - Brooklyn NY

Endometriosis - Staten Island NY

Asthma in Children (Ages 5-11) - Nottingham MD

Asthma in Children (Ages 5-11) - Verona NJ

Asthma in Children (Ages 5 - Asbury Park NJ

Asthma - Edison NJ

Asthma - Baltimore MD

Asthma - Ocean NJ

Alzheimer's Disease - New York NY

COPD (Emphysema and Chronic Bronchitis) - Towson MD

COPD (Emphysema and Chronic Bronchitis) - Bronx NY